MAPT and Alzheimer disease: In the present study, we have evaluated the LPO indicators: HNE and MDA, redox peptides: GSH and GSSG, in order to validate their use as potential oxidative stress markers of AD by correlating their levels with known pathological markers namely Aβ42 and total tau in AD blood samples.